Marinova is proud to announce that new research featuring Maritech® fucoidan extracts in polyelectrolyte multilayers (PEMs) has been accepted by the highly esteemed physical chemistry journal, Langmuir. Read more
The latest addition to the growing body of peer-reviewed fucoidan literature is Therapies from Fucoidan: An Update – a review published in the latest issue from Marine Drugs and written by Marinova’s Chief Scientist. Read more
TV and media presenter Guy Fenton chats with leading marine scientist, Dr Pia Winberg, about Marinova and the process of extracting fucoidan from seaweed. This video is an excellent visual snap shot of what we do here at Marinova and the foundations of our research. Read more
The Festival of Bright Ideas is a unique opportunity for the Tasmanian science sector to showcase itself in an interactive – and entertaining – way to both school students and the general public. Read more
New research published in the international journal PLOS ONE supports the potential for Maritech® fucoidan extracts to combat inflammatory bowel disorders. Read more
HOBART, Australia – Breakthrough research published for the first time today has confirmed the potential for a unique seaweed extract to combat inflammatory bowel disorders. Read more
Maritech® Reverse, a high purity fucoidan extract manufactured by Marinova, has been announced as the winner of the silver medal at the Green Cosmetic Ingredient Awards in Barcelona, Spain. Read more
Marinova is pleased to announce the publication of novel research into the use of Maritech® fucoidan in forming Polyelectrolyte Multilayers (PEMs). Read more
Marinova is pleased to announce the successful completion of an integrative oncology trial involving one of its lead fucoidan products Read more
Until recently, seaweed has played a very limited role in Australian cuisine. Apart from incorporating into novel dishes by more adventurous gourmet chefs, Read more
